Company intelligence / Profile preview

BioLabs

Ownership: Private
Development stage: Other

Overview

BioLabs operates as an international network of shared laboratory and office facilities for early-stage life science startups. It provides state-of-the-art lab space, business services, access to equipment, and a collaborative community. Over 500 member companies have raised more than $5B collectively. The company does not conduct its own clinical trials.

Therapeutic areas: Other
Modalities: All therapeutic modalities
Industry: Drug Discovery Services

Partnerships

PromegaNYU Langone Health

Beyond the preview

Go deeper on BioLabs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioLabs.

Explore the full profile